Kappa and AC1/2 statistics: beyond the paradox

Affiliations

¹ Department of Epidemiology, Lazio Regional Health Service, Rome, Italy. Electronic address: minozzi.silvia@gmail.com.
² Laboratorio di Metodologia delle revisioni sistematiche e produzione di Linee Guida, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
³ Unit of Clinical Epidemiology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
⁴ Center for Health Regulatory Policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Comment

Silvia Minozzi et al. J Clin Epidemiol. 2022 Feb.

. 2022 Feb:142:328-329.

doi: 10.1016/j.jclinepi.2021.09.004. Epub 2021 Sep 11.

¹ Department of Epidemiology, Lazio Regional Health Service, Rome, Italy. Electronic address: minozzi.silvia@gmail.com.
² Laboratorio di Metodologia delle revisioni sistematiche e produzione di Linee Guida, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
³ Unit of Clinical Epidemiology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
⁴ Center for Health Regulatory Policies, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

No abstract available

Comment on

The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application.
Minozzi S, Cinquini M, Gianola S, Gonzalez-Lorenzo M, Banzi R. Minozzi S, et al. J Clin Epidemiol. 2020 Oct;126:37-44. doi: 10.1016/j.jclinepi.2020.06.015. Epub 2020 Jun 18. J Clin Epidemiol. 2020. PMID: 32562833
Interrater reliability of ROB2 - an alternative measure and way of categorization.
Loef M, Walach H, Schmidt S. Loef M, et al. J Clin Epidemiol. 2022 Feb;142:326-327. doi: 10.1016/j.jclinepi.2021.09.003. Epub 2021 Sep 9. J Clin Epidemiol. 2022. PMID: 34509629 No abstract available.